GW Pharmaceuticals Plc (GWPH)

117.60
1.50 1.30
NASDAQ : Health Technology
Prev Close 119.12
Open 119.52
Day Low/High 115.68 / 121.53
52 Wk Low/High 90.14 / 196.00
Volume 341.63K
Avg Volume 605.10K
Exchange NASDAQ
Shares Outstanding 30.72M
Market Cap 3.68B
EPS -9.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
Cramer: I'm Impressed by GW Pharma's Cannabis Data, Wait to Buy Kimberly-Clark

Cramer: I'm Impressed by GW Pharma's Cannabis Data, Wait to Buy Kimberly-Clark

GW Pharma's drug showed impressive results for treating schizophrenia, Cramer says. Investors looking to buy high-quality consumer companies like Kimberly-Clark should wait for the Fed's rate decision.

Jim Cramer: Rite Aid and GW Pharmaceuticals Are Ripe for a Rally

Jim Cramer: Rite Aid and GW Pharmaceuticals Are Ripe for a Rally

Rite Aid and GW Pharmaceuticals both have positive catalysts — and bullish analyst coverage — to help push their share prices higher, Cramer says.

'Mad Money' Lightning Round: Sell, Sell, Sell LinkedIn

'Mad Money' Lightning Round: Sell, Sell, Sell LinkedIn

Cramer says we're too late on NutriSystem while AmerisourceBergen is a terrific buy.

Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China

Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China

China's problems continue to knock a number of U.S. stocks upside the head, Cramer says.

Jim Cramer's Top Takeaways: Domino's, GW Pharmaceuticals, Bed Bath & Beyond

Jim Cramer's Top Takeaways: Domino's, GW Pharmaceuticals, Bed Bath & Beyond

Cramer is sticking with Domino's in the pizza wars and he likes Bed Bath the store but not the stock.

Jim Cramer's 'Mad Money' Recap: Supreme Court Almost Makes Market Forget Greece

Jim Cramer's 'Mad Money' Recap: Supreme Court Almost Makes Market Forget Greece

Health care stocks rose after the High Court's ruling but don't expect magic for everyone until there's a Greek deal.

Marijuana Stocks and the Risks of a '420 Friendly' Portfolio

Marijuana Stocks and the Risks of a '420 Friendly' Portfolio

Want to invest in marijuana stocks? You'd better do your homework first -- otherwise, you might get burned.

Jim Cramer Explains What Markets Will Do When the Fed Raises Rates

Jim Cramer Explains What Markets Will Do When the Fed Raises Rates

Answering a viewer's Twitter question, Jim Cramer says market will dip for several weeks after the Federal Reserve raises rates.

Cramer: Markets to Dip for a Few Weeks When the Fed Raises Rates

Cramer: Markets to Dip for a Few Weeks When the Fed Raises Rates

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

GW Appoints Senior Industry Executive To President, North America And Relocates CEO To The U.S.

GW Appoints Senior Industry Executive To President, North America And Relocates CEO To The U.S.

U.S. Operations to be Located in Southern California

GW Pharmaceuticals Plc Reports Second Quarter 2015 Financial Results And Operational Progress

GW Pharmaceuticals Plc Reports Second Quarter 2015 Financial Results And Operational Progress

Conference Call Today at 8:00 a.m. EDT, 1:00 p.m. BST

Here's What's Driving Biotech

And it's not the favorable macroeconomic climate.

That Was the Week That Was

That Was the Week That Was

Let's review.